͵͵

News

Chemists build synthetic catalysts to break down biomass like super enzymes

Mike Krapfl
By Mike Krapfl
Sept. 9, 2023

gestured toward the trees outside his campus window on a rainy afternoon.

The professor of chemistry at Iowa State University is developing new synthetic catalysts to break down cellulose, the plant fibers that make those trees tall and strong.

Yan Zhao is working to develop synthetic catalysts that could help industry break down plant fibers for fuels and chemicals.
Christopher Gannon
Yan Zhao is working to develop synthetic catalysts that could help industry break down plant fibers for fuels and chemicals.

“Cellulose is built to last — a tree doesn’t just disappear after rain,” Zhao said. “Cellulose is a huge challenge to break down.”

Zhao thinks he has an idea and a technology that can get the job done, making plant biomass a practical source of sugars that can be converted to many applications, including fuels and chemicals.

Learning from Mother Nature

The synthetic catalysts Zhao and his research group are developing are like super enzymes, able to break down cellulose like their natural counterparts, but in more extreme environments and after being recycled over and over.

“We’re taking our inspiration from biology,” Zhao said. “We’re trying to duplicate the features of natural enzymes. And so far, we have good results.”

Enzymes are natural proteins that act as catalysts, regulating the chemical reactions that keep biological processes going and living beings functioning. Enzymes, for example, catalyze cell metabolism, including breaking down food for digestion.

Three enzymes — endocellulase, exocellulase and beta-glucosidase — can break down and digest plant fiber, or cellulose.

Natural enzymes would seem to be a good place for industries to turn for cellulose processing. But they’re expensive. They can’t survive high temperatures or nonaqueous solvents. And they’re unstable and difficult to recycle back into production.

Zhao’s research group has worked about 10 years to develop nanoparticle catalysts capable of resolving those issues. Grants from the and the have supported that work. The is pursuing patent protection of the technology and is seeking commercial partners.

from the NSF (with $400,000 for Iowa State research) will advance Zhao’s latest ideas about enzyme-mimicking catalysts. The new project includes computer simulations of the active reaction sites by at Northeastern University in Boston.

The simulations, Zhao said, “will help us to better understand our system. This is a very complex system.”

Making the most of micelles

Zhao’s research group is taking advantage of dynamic nanospheres known as micelles. They assemble themselves when chains of surfactant molecules (which reduce surface tension in liquids) are exposed to water, causing the hydrophilic, water-loving heads of the molecules to form an exterior shell and the water-hating, hydrophobic tails to turn inside that shell.

Zhao and his group have found a way for micelles to assemble around active-site-resembling template molecules. Once solidified by ultraviolet light, these “molecularly imprinted nanoparticles” are 5 billionths of a meter in size and have the exact shape and size to mimic the binding and catalytic properties of natural enzymes. The nanoparticles have catalytic groups directly pointed to sugar linkages in cellulose polymers to break them down efficiently and selectively.

“If successful, the research will yield synthetic catalysts for cellulose (breakdown) that can compete with natural cellulases in activity but are much easier to prepare and recycle,” according to a project summary.

That could make them a viable option for industry, said Zhao, who’s interested in establishing partnerships with companies.

The technology, after all, fits the state and the times.

“Biomass conversion is a big deal not only to the state of Iowa,” Zhao said, noting a potential market for the biomass grown in farm fields across the state, “but the world right now is interested in a carbon-neutral economy and sustainability.”

This article was first published by the Iowa State University News Service.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Mike Krapfl
Mike Krapfl

Mike Krapfl is a communications specialist at Iowa State University.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.

From the journals: JLR
Journal News

From the journals: JLR

Nov. 15, 2024

Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.